0069-0227 : Lorbrena 25 mg Oral Tablet, Film Coated
| NDC: | 0069-0227 |
| Labeler: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Lorbrena |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA210868 |
| Rev. Date: |
Appearance:
| Markings: | Pfizer;25;LLN |
| Shapes: |
Round |
| Colors: |
 Brown |
| Size (mm): | 8 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0069-0227-01: 30 TABLET, FILM COATED IN 1 BOTTLE (0069‑0227‑01)
Active Ingredients:
- Lorlatinib
Dosage Strength:
- 25 mg
Pharmaceutical Classes:
- Cytochrome P450 3A4 Inducers [MoA]
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0069-0231 Lorbrena 100 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
- 63539-927 Lorbrena 25 mg Oral Tablet, Film Coated by U.S. Pharmaceuticals
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0069-0223Next: 0069-0228 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.